The $12.5 Trillion Demographic Wave Wall Street Keeps Misprice
America’s aging population isn’t just a healthcare story. It’s a home infrastructure story.
Netflix Is Down 24% in Three Months. July 16 Is When the Real Story Starts.
A $3B ad revenue target, 325M+ paid members, and a stock near 52-week lows all collide at Q2 earnings.
Meta Is Down 16% From Its High. The Real Story Starts July 29.
Revenue grew 33% in Q1. The AI cloud pivot could change everything.
The $54 Billion Drone Budget Has a Supply Chain Problem Nobody Is Solving
Washington is flooding the zone with drone money. The real bottleneck isn’t drones — it’s who builds the parts.
SpaceX Is Down ~36% From Its IPO Peak. August 6 Is When the Float Changes.
Starlink at ~10.3M subscribers, ~$4.7B in Q1 revenue, and a lockup window that could rewrite the supply-demand equation.
Eli Lilly Is Growing Like a Software Company. The Valuation Debate Is Getting Loud.
Mounjaro sales up 125% in Q1. A new pill just launched. Q2 earnings could reset the story again.
MercadoLibre Is Down About 37% From Its High. Its Fastest Growth in Years Just Got Ignored.
Revenue grew 49% last quarter. The market punished it anyway.
The AI Chip Crisis Nobody Is Measuring Correctly
Inside the invisible yield bottleneck deciding which AI factories actually ship.
Lam Research Is Down About 19% From Its Peak. July 29 Earnings Could Reset the Entire Chip Equipment Trade.
Record $5.84B revenue, a $140B WFE outlook, and a sector that just got a wave of analyst target hikes.
Circle Just Became a Bank. The Real Story Is What Comes Next.
The OCC approval is the headline. The GENIUS Act deadline eight days away is the trade.